Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04239560Phase 3Completed
Phase 3, randomised, double-blind trial in radiation dermatitis comparing Boron-based Gel with Placebo (2 arms). Primary endpoint: Radiation Therapy Oncology Group (RTOG) criteria for Radiation Dermatitis at Day 25. Started Feb 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04239560.